AGILON HEALTH INC's ticker is AGL and the CUSIP is 00857U107. A total of 207 filers reported holding AGILON HEALTH INC in Q2 2024. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,687 | +7.5% | 562,400 | 0.0% | 3.97% | +24.7% |
| Q1 2024 | $3,431 | -51.4% | 562,400 | 0.0% | 3.18% | -49.3% |
| Q4 2023 | $7,058 | -29.3% | 562,400 | 0.0% | 6.29% | -18.6% |
| Q3 2023 | $9,988 | -48.2% | 562,400 | -49.4% | 7.72% | -59.1% |
| Q2 2023 | $19,289 | -27.0% | 1,112,400 | 0.0% | 18.90% | -19.7% |
| Q1 2023 | $26,420 | +47.2% | 1,112,400 | 0.0% | 23.54% | +36.7% |
| Q4 2022 | $17,954 | -99.9% | 1,112,400 | 0.0% | 17.22% | -32.9% |
| Q3 2022 | $26,052,000 | +7.3% | 1,112,400 | 0.0% | 25.65% | +0.8% |
| Q2 2022 | $24,284,000 | -13.9% | 1,112,400 | 0.0% | 25.46% | +8.9% |
| Q1 2022 | $28,199,000 | -6.1% | 1,112,400 | 0.0% | 23.38% | -14.9% |
| Q4 2021 | $30,035,000 | +3.0% | 1,112,400 | 0.0% | 27.47% | -3.5% |
| Q3 2021 | $29,156,000 | -35.4% | 1,112,400 | 0.0% | 28.46% | -24.2% |
| Q2 2021 | $45,130,000 | – | 1,112,400 | – | 37.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clayton, Dubilier & Rice, LLC | 194,611,308 | $4,622,018,565 | 50.06% |
| NORTHWESTERN UNIVERSITY | 1,112,400 | $26,420 | 23.54% |
| YARGER WEALTH STRATEGIES, LLC | 173,167 | $4,112,716 | 4.51% |
| Rock Springs Capital Management LP | 7,882,500 | $187,209,375 | 4.47% |
| Engle Capital Management, L.P. | 417,400 | $9,913,250 | 3.25% |
| Durable Capital Partners LP | 5,503,139 | $130,699,551 | 1.23% |
| Renaissance Capital LLC | 62,916 | $1,494,255 | 1.11% |
| Beck Bode, LLC | 170,036 | $4,038,352 | 0.99% |
| Sciencast Management LP | 22,468 | $543,501 | 0.72% |
| Advantage Alpha Capital Partners LP | 145,405 | $3,453,369 | 0.72% |